Cynthia Schwalm serves as Executive at G1 Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Cynthia Schwalm has executed 7 insider transactions totaling $126.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 17, 2021 involved receiving (via award) 4,389 shares valued at $0.
Cynthia Schwalm currently holds 5,889 shares of G1 Therapeutics, Inc. (GTHX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cynthia Schwalm has been a net buyer of GTHX stock. They have purchased $126.6K and sold $0 worth of shares.
Cynthia Schwalm's most recent insider trade was on Jun 17, 2021, when they sold 4,389 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 12, 2020 | KDMN | $30.2K | Purchase | 9,307 | $3.24 | Discretionary |
| Mar 12, 2020 | KDMN | $70.3K | Purchase | 21,693 | $3.24 | Discretionary |
| Jan 13, 2020 | CLBS | $60.0K | Award | 18,292 | $3.28 | Discretionary |
| Jan 14, 2019 | CLBS | $60.0K | Award | 12,121 | $4.95 | Discretionary |
| Dec 26, 2018 | GTHX | $26.2K | Purchase | 1,420 | $18.45 | Discretionary |